TrialNet: Diabetes Type 1 Prevention
Description: PUBLIC HEALTH RELEVANCE: There are more than 1 .5 million with Type 1 diabetes in the United States and probably as many who may develop it over their lifetime. The cost of treating this disease and its complications is a major issue for our health care system. Type 1 Diabetes TrialNet was constituted to find therapies which would prevent and reverse this autoimmune disease. Although progress has been made to temporarily halt disease progression, more work to permanently stop it remains. It is the ongoing goal of the TrialNet Network through the excellent conduct of clinical trials and incorporation of relevant mechanistic studies to find treatments that can achieve these ends.
Funding type: cooperative_agreement
Funder scheme: U01
Start date: 2009-09-30
End date: 2020-04-30
Investigator: PETER A GOTTLIEB
Institution: UNIVERSITY OF COLORADO DENVER
Subfield: Genetics
Domain: Life Sciences
Funded outputs count: 181
Funder award ID: U01DK085509
OpenAlex ID: G8090474474